Akbarzadeh Mohammadali, Haghjoo Majid
Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran.
Res Cardiovasc Med. 2014 May;3(2):e17113. doi: 10.5812/cardiovascmed.17113. Epub 2014 Apr 1.
Brugada Syndrome is a cardiac ion channel disorder that affects the sodium current. This syndrome is characterized by cove-shaped ST elevation in ECG leads V1 to V3 in the absence of structural heart disease.
A 36-year-old man diagnosed with Brugada Syndrome was reffered to our center with frequent implantable cardioverter-defibrillator (ICD) discharges. ICD interrogation showed several appropriate ICD intervention for tachycardia detected in the ventricular fibrillation zone. Unfortunately, quinidine was not available in our country at the time of admission; therefore, we decided to ablate suspicious arrhythmogenic substrates. Programmed ventricular stimulation from right ventricle (RV) reproducibly induced a sustained ventricular tachycardia with left bundle branch block morphology and inferior axis. RV outflow tract (RVOT) endocardially mapped and earliest activation signal (90 milliseconds) achieved at posterior aspect of the RVOT septum. RF energy application at that site terminated the tachycardia and no inducible tachycardia was detected. During two-year follow-up, he had no episodes of ICD therapy and remained symptom-free with any antiarrhythmic drug.
This case clearly indicated that catheter ablation might be considered as a viable option in every patient with Brugada syndrome and frequent ICD discharge. During the electrophysiology study, intravenous procainamide may also be used to reveal future arrhythmogenic focus in this group of patients.
Brugada综合征是一种影响钠电流的心脏离子通道疾病。该综合征的特征是在无结构性心脏病的情况下,心电图V1至V3导联出现穹窿样ST段抬高。
一名36岁被诊断为Brugada综合征的男性因植入式心律转复除颤器(ICD)频繁放电被转诊至我院。ICD问询显示对心室颤动区域检测到的心动过速进行了几次适当的ICD干预。不幸的是,入院时我国没有奎尼丁;因此,我们决定消融可疑的致心律失常基质。右心室(RV)程序性心室刺激可重复性地诱发一种具有左束支传导阻滞形态和下轴的持续性室性心动过速。对右心室流出道(RVOT)进行心内膜标测,在RVOT间隔后部获得最早激活信号(90毫秒)。在该部位施加射频能量终止了心动过速,未检测到可诱发的心动过速。在两年的随访期间,他没有发生ICD治疗事件,未服用任何抗心律失常药物,也无症状。
该病例清楚地表明,对于每一位患有Brugada综合征且ICD频繁放电的患者,导管消融可能是一种可行的选择。在电生理研究期间,静脉注射普鲁卡因胺也可用于揭示该组患者未来的致心律失常灶。